Medley Therapeutics, Inc.

Private

Laguna Hills, CaliforniaHealthcare & Life Scienceshttps://www.medleytx.com/

Last Round

Series B

Jan 12, 2022

Total Funding Raised

$30.06M

Company Overview

Medley Therapeutics, Inc. is a biotechnology company developing regenerative genetic medicines and advanced biologics to treat chronic and life-threatening diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

gene therapycardiac regenerationAAV gene therapyheart failure therapyHippo pathway modulationregenerative medicineclinical-stage biotechheart failure with reduced ejection fractionHFrEFadeno-associated virusAAVshort hairpin RNAshRNARNAi therapygene silencingadvanced biologicsradiopharmaceuticals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medley Therapeutics, Inc. Comps

Public and private peers based on sector, stage, and business model.

Medley Therapeutics, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Medley Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jan 12, 2022

View all Funding Rounds

Medley Therapeutics, Inc. Investors

Notable investors and investment history

Medley Therapeutics, Inc. investors
Investor	Rounds
Fjord Ventures	Series B
ArrowMark Partners	Series B
BCM Ventures	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 12, 2022
$30M round with ArrowMark Partners, BCM Ventures, and Fjord Ventures.

View all signals

Medley Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Medley Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medley Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersLaguna Hills, California

Year FoundedN/A

Last FundingJan 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.